These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16532978)

  • 1. Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening.
    Theuer CP; Taylor TH; Brewster WR; Anton-Culver H
    J Natl Med Assoc; 2006 Jan; 98(1):51-7. PubMed ID: 16532978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States.
    Theuer CP; Wagner JL; Taylor TH; Brewster WR; Tran D; McLaren CE; Anton-Culver H
    Gastroenterology; 2001 Mar; 120(4):848-56. PubMed ID: 11231939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.
    Wu GH; Wang YM; Yen AM; Wong JM; Lai HC; Warwick J; Chen TH
    BMC Cancer; 2006 May; 6():136. PubMed ID: 16723013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy.
    Theuer CP; Taylor TH; Brewster WR; Campbell BS; Becerra JC; Anton-Culver H
    Am Surg; 2001 Dec; 67(12):1157-61. PubMed ID: 11768820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of screening the average-risk population for colorectal cancer.
    Provenzale D
    Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):93-109. PubMed ID: 11916165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults.
    Khandker RK; Dulski JD; Kilpatrick JB; Ellis RP; Mitchell JB; Baine WB
    Int J Technol Assess Health Care; 2000; 16(3):799-810. PubMed ID: 11028135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
    Allameh Z; Davari M; Emami MH
    Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing risks and benefits of colorectal cancer screening in elderly patients.
    Ko CW; Sonnenberg A
    Gastroenterology; 2005 Oct; 129(4):1163-70. PubMed ID: 16230070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of colorectal cancer screening.
    McMahon PM; Bosch JL; Gleason S; Halpern EF; Lester JS; Gazelle GS
    Radiology; 2001 Apr; 219(1):44-50. PubMed ID: 11274533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gender-specific influences on incidence, screening, treatment, and outcome of colorectal cancer].
    Grundmann RT; Meyer F
    Zentralbl Chir; 2013 Aug; 138(4):434-41. PubMed ID: 23950079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
    Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
    Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening based on risk for colorectal cancer is the most cost-effective approach.
    Dan YY; Chuah BY; Koh DC; Yeoh KG
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.
    Fisher JA; Fikry C; Troxel AB
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):108-13. PubMed ID: 16434595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of colorectal cancer screening in the elderly.
    Wagner JL; Herdman RC; Wadhwa S
    Ann Intern Med; 1991 Nov; 115(10):807-17. PubMed ID: 1929029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.